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The methanolic extract (TAE) together with three alkaloids identified as Kokusaginine (1), Maculine (2), Kolbisine (4) and a common
terpenoid, Lupeol (3), isolated from the stem bark of Teclea afzelii were tested for their antimicrobial activity against Gram-positive and negative
bacteria, fungi and Mycobacterium smegmatis. Agar diffusion assay was used for the determination of the sensitivity of test organisms to the
samples. The micro-dilution method to determine the Minimal Inhibition Concentration (MIC) and the Minimal Microbicidal Concentration
(MMC). The results of the diffusion test showed that only compound 1 was active on all the tested micro-organisms, whilst the inhibition effect of
the crude extract and that of compounds 2 and 4 was observed on 87.5% of the tested microbial species. The lowest MIC value (19.53 μg/ml) for
the crude extract was obtained on Escherichia coli, Bacillus subtilis and Microsporum audorium. The corresponding value for the tested
compounds (2.44 μg/ml) was recorded with compound 2 on B. subtilis. The crude extract, compounds 2 and 3 showed moderate activity against
M. smegmatis. The overall results provide promising basis for the use of the crude extract as well as the isolated alkaloids in the treatment of
specific microbial infections.
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Teclea afzelii Engl. (Rutaceae) is a shrub of about 5 m height
that grows in the humid rain forest of tropical Africa, from Sierra
Leone to Cameroon. It forms a part of the sub-family
Toddaliodeae, which, as present in Africa, consist of 50 to 100
species distributed between a number of closely related and
taxonomically difficult genera (Khalid and Waterman, 1981).⁎ Corresponding author. Department of Biochemistry, Faculty of Science,
University of Yaoundé I. PO Box 812, Yaoundé, Cameroon. Tel.: +237 735 59
27/237 533 84 55; fax: +237 222 60 18.
E-mail address: kuetevictor@yahoo.fr (V. Kuete).
0254-6299/$ - see front matter © 2008 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2008.02.004This plant is used in the Cameroonian folk medicine in the
treatment of wounds infections, abdominal pains, cough, fever
and asthma (Adnan et al., 2003; Personal communication). From
the available literature, no scientific report has yet been focussed
on the antimicrobial activity of plant from the genus Teclea,
though many phytochemical investigations on this genus
resulted in the isolation of alkaloids and terpenoids, two
known classes of bioactive metabolites. Some of the compounds
isolated from this genus include skimmianine, flindersiamine,
tecleaverdoornine, tecleaverdine, tecleine, montrifoline, nkolbi-
sine, tecleamine, flindersiamine, tecleanatalensine A, tecleana-
talensine B (alkaloids) and lupeol (terpenoid) (Tarus et al., 2005;
Ayafor et al., 1982). Our continuing search of antimicrobial
drugs from natural products includes plants of the familyts reserved.
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undertaken to assess the antibacterial and antifungal activities of
the methanolic extract from the stem bark of T. afzelii.
2. Materials and methods
2.1. Plant material and extraction
The stem bark of T. afzelii were collected in December 2005
at Elounden (Centre province of Cameroon). The botanical
identification of the plant was done at the Cameroon National
Herbarium, where the voucher specimen was conserved under
the reference number 10674/SRF/Cam.
2.2. Purification and general procedures
The sun-dried and powdered stem bark (2.5 kg) of T. afzelii
were macerated in Methanol (8 L) at room temperature for 48 h.
The filtrate was then concentrated under vacuum to give a dark
brown crude extract (TAE) (450 g).
One hundred and fifty grams (150 g) of TAE were subjected
to column chromatography over silica gel 60 (180 g) and eluted
with hexane-ethyl acetate (hexane-EtOAc) gradient. One
hundred and twenty sub-fractions of 250 ml each were collected
and pooled following analytic TLC. After 2 h, fraction 14
yielded Kokusaginine C14H13O4N (1) (20.5 mg; white powder,
MW: 259; m.p: 168–170 °C) (Briggs and Cambie, 1958; Mester
and Inescu, 1971; Oliveira et al., 1996) as a precipitate. Fraction
20 after re-crystallization afforded Maculine C13H9NO4 (2)
(35.0 mg; white powder; MW: 243; m.p: 196–197 °C) (Oliveira
et al., 1996). Fraction 28 after re-crystallization within 1 h
yielded white pallets identified as Lupeol C30H50O (3)
(15.8 mg; MW: 426; m.p: 214–216 °C). Combined fractions
34–36, after 24 h at room temperature afforded brown crystals,
Kolbisine C18H12O6N (4) (28.5 mg; MW: 347; m.p: 190 °C)
(Sener et al., 1987). The chemical structures of the isolated
compounds are presented on Fig. 1.
Aluminium sheet pre-coated with silica gel 60 F254 nm
(Merck) was used for thin layer chromatography and the
isolated spots were visualized using both ultra-violet light (254Fig. 1. Chemical structures of compounds isolated from the stem barks of Teclea
afzelii.and 366 nm) and 50% H2SO4 spray reagent. The chemical
structure of each of the isolated compound was determined on
the basis of spectral data produced by one and two-dimensional
nuclear magnetic resonance (NMR), recorded on Brüker DRX-
400 instrument. This spectrometer was equipped with 5-mm,
1H- and 13C-NMR probes operating at 400 and 100 MHz, with
tretramethylsilane as internal standard. Mass spectra were
recorded on a API QSTAR pulsar mass spectrometer. The
structures of the compounds were confirmed by comparing with
reference data from available literature.
2.3. Antimicrobial assays
2.3.1. Microbial strains
Nine species of microorganisms namely Mycobacterium
smegmatis (ATCC 700084), Bacillus subtilis LMP0304G, Sta-
phylococcus aureus LMP0206U, Escherichia coli LMP0101U,
Pseudomonas aeruginosa LMP0102U, Salmonella typhi
LMP0209U, Candida albicans LMP0204U, Candida gabrata
LMP0413U and Microsporum audorium LMP 0724D were
used in this study. M. smegmatis was obtained from American
Type Culture Collection, MD, USA and the antimicrobial test
on this strain was performed at the Department of Plant Science,
University of Pretoria. Other strains were clinical isolates from
‘Centre Pasteur du Cameroon’, Yaoundé. Their identity was
confirmed before use at the LMP by culturing on the specific
media followed by biochemical test using API system: S. typhi
(SS agar; API 20E) (bioMérieux), E. coli, (C.L.E.D agar;
API20E) (bioMérieux), P. aeruginosa (PSM agar, API20E)
(bioMérieux), S. aureus. [Chapman agar; API 32Staph)
(bioMérieux)], B. subtilis [NA (Oxoid) containing bromocresol
purple; API 50 CH)], Candida sp [ChromagarTM Candida
(Becton-Dickinson); API 20C AUX (bioMérieux)],M. audorium
[SDA 1% chloramphenicol; API20C) (bioMérieux)] (Mbaveng
et al., 2008).
They were maintained on agar slant at 4 °C in the Laboratory
of Applied Microbiology and Molecular Pharmacology (LMP)
(Faculty of Science, University of Yaoundé I) where the
antimicrobial tests were conducted. These strains were sub-
cultured on a fresh appropriate agar plate 24 h prior to any
antimicrobial test.
2.3.2. Antimicrobial assays
2.3.2.1. Culture media. M. smegmatis was cultured onto
Middlebrook 7H11 agar and allowed to grow for 24 h. Nutrient
Agar (NA) containing Bromocresol purple was used for the
activation of Bacillus species while NA was used for other
bacteria. Sabouraud Glucose Agar was used for the activation of
the fungi. Nutrient broth containing 0.05% phenol red and
supplemented with 10% glucose (NBGP) was used for MIC and
MMC determination. The Mueller Hinton Agar (MHA) was
also used for the determination of the MMC.
2.3.2.2. Chemicals for antimicrobial assay. Ciprofloxacin
(Sigma-Aldrich Chemical Co., South Africa) was used as
reference antibiotic (RA) for M. smegmatis. Nystatin (Maneesh
Table 1
Inhibition zone diameters a (mm) of the crude extract, compounds isolated from
T. afzelii and reference antibiotics determined by the disc diffusion test
Microorganisms Tested samples b
Crude extract Isolated compounds
TAE 1 2 3 4 RA
Mycobacteria
M. smegmatis nt nt nt nt nt nt
Gram-negative
bacteria
Escherichia coli 17.5±0.5 21.0±
1.0
– 10.0±
0.0
– 22.0±
0.0
Pseudomonas
aeruginosa
– – 12.5±
0.5
– – 20.0±
1.0
Salmonella typhi 14.5±0.0 18.0±
0.0
19.5±
0.0
– 18.5±
0.5
23.0±
0.0
Gram-positive
bacteria
Staphylococcus
aureus
– 13.0±
0.0
– – – 22.0±
0.0
Bacillus subtilis 17.5±0.5 22.5±
0.0
24.0±
0.0
– 21.0±
0.5
22.0±
0.5
Fungi
Candida albicans 15.0±0.0 17.5±
0.0
20.0±
1.0
– 19.0±
0.5
24.5±
0.5
Candida gabrata 14.0±0.5 18.0±
1.0
18.5±
0.5
– 20.0±
1.0
23.5±
0.0
Microsporum
audorium
16.0±1.0 22.0±
0.0
21.0±
0.0
22.0±
0.0
26.0±
0.0
(nt): Not tested; (–): Not active.
a Tested samples: crude extract was tested at 200 µg/disc, compounds at
100 µg/disc and RA at 20 µg/disc.
b The Tested samples were crude extract from T. afzelii (TAE), 1: Kokusaginine;
2: Maculine; 3: Lupeol; 4: Kolbisine; RA: Reference antibiotics (Gentamycin for
bacteria, Nystatin for yeasts).
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gentamycin {Jinling Pharmaceutic (Group) corp., Zhejang
Tieng Feng Pharmaceutic Factory, No. 11 Chezhan Road,
Huzhou city, Zhejang, China) were used as RA against yeasts
and other bacteria respectively.
2.3.2.3. Antimicrobial assays
2.3.2.3.1. Microplate susceptibility testing against M.
smegmatis. All extracts were tested against M. smegmatis
using microplate dilution method. The MIC, MBC and bacteria
preparation were performed in 96-well microplates according to
Salie et al. (1996) and Newton et al. (2002). The crude extracts
were dissolved in 10% dimethylsulfoxide (DMSO) in sterile
7H9 broth to obtain a stock concentration of 1.250 mg/ml.
Serial two-fold dilutions of each sample to be evaluated were
made with 7H9 broth to yield volumes of 100 µl/well with final
concentrations ranging from 9.76–312.50 µg/ml. Ciprofloxacin
served as the positive drug control. 100 µl of M. smegmatis
(0.2 log-phase, yielding 1.5×106 CFU/ml) was also added to
each well containing the samples and mixed thoroughly to give
final concentrations ranging from 0.31–19.53 µg/ml. The
solvent control, DMSO at 2.5% or less in each well did not
show inhibitory effects on the growth of the M. smegmatis.
Tests were done in triplicates. The cultured microplates were
sealed with parafilm and incubated at 37 °C for 24 h. The MIC
of samples was detected following addition (40 µl) of 0.2 mg/ml
p-iodonitrotetrazolium chloride (INT, Sigma-Aldrich, South
Africa) and incubated at 37 °C for 30 min (Eloff, 1998;
Mativandlela et al., 2006). Viable bacteria reduced the yellow
dye to a pink colour. MIC was defined as the lowest sample
concentration that prevented this change and exhibited
complete inhibition of bacterial growth. The MBC was
determined by adding 50 µl aliquots of the preparations
(without INT), which did not show any growth after incubation
during MIC assays, to 150 µl of 7H9 broth. These preparations
were incubated at 37 °C for 48 h. The MBC was regarded as the
lowest concentration of extract, which did not produce a colour
change after addition of INT as above mentioned.
2.3.2.3.2. Antimicrobial assay on Gram-positive, Gram-
negative bacteria and fungi.
2.3.2.3.2.1. Sensitivity test: agar disc diffusion assay
2.3.2.3.2.1.1. Preparation of discs. Whatmann filter paper
(No. 1) discs of 6 mm diameter were impregnated with 10 µl of
the solution of crude extract at 20 mg/ml (200 µg/disc) and
isolated compounds at 10 mg/ml (10 µg/disc) prepared using
DMSO. The discs were evaporated at 37 °C for 24 h. The RA
discs were prepared as described above using the appropriate
concentrations to obtain discs containing 20 µg of drug. Two
discs were prepared for each sample.
2.3.2.3.2.1.2. Diffusion test. The antimicrobial diffusion
test was carried out as described by Berghe and Vlietinck (1991)
using a cell suspension of about 1.5 106 CFU/ml obtained from
a McFarland turbidity standard N° 0.5. The suspension was
standardised by adjusting the optical density to 0.1 at 600 nm
(SHIMADZU UV-120-01 spectrophotometer) (Tereschuk et al.,
1997). This was used to inoculate by flooding the surface of
MHA plates. Excess liquid was air-dried under a sterile hoodand the impregnated discs were applied at equidistant points on
top of the agar medium. A disc prepared with only the
corresponding volume of DMSO was used as negative control.
The plates were incubated at 37 °C for 24 h. Antimicrobial
activity was evaluated by measuring the diameter of the
inhibition zone (IZ) around the disc. The assay was repeated
twice and results were recorded as mean±SD of the duplicated
experiment.
2.3.2.3.2.2. MIC and MMC determinations. The MICs of
test samples and RAwere determined as follows: the test sample
was first of all dissolved in DMSO. The solution obtained was
added to NBGP to a final concentration of 78.12 µg/ml for each
sample. This was serially diluted two fold to obtain concentra-
tion ranges of 0.61 to 78.12 µg/ml. 100 µl of each concentration
was added in each well (96-wells microplate) containing 95 µl
of NBGP and 5 µl of inoculum (standardised at 1.5 106 CFU/ml
by adjusting the optical density to 0.1 at 600 nm SHIMADZU
UV-120-01 spectrophotometer) (Tereschuk et al., 1997). The
final concentration of DMSO and Tween in the well was less
than 1% (preliminary analyses with 1% (v/v) DMSO/NBGP
affected neither the growth of the test organisms nor the change
of colour due to this growth). The negative control well
consisted of 195 µl of NBGP and 5 µl of the standard inoculum
(Zgoda and Porter, 2001; Kuete et al., 2007). The plates were
covered with a sterile plate sealer, then agitated to mix the
Table 3
Minimal microbicidal concentration (μg/ml) of the crude extracts, compounds
isolated from T. afzelii and reference antibiotics
Microorganisms Tested samples a
Crude
extract
Isolated compounds
TAE 1 2 3 4 RA
Mycobacteria
M. smegmatis 312.50 N312.5 312.50 – N312.5 1.22
Gram-negative
bacteria
Escherichia
coli
78.12 9.76 – N78.12 – 9.76
Pseudomonas
aeruginosa
– N78.12 N78.12 – N78.12 19.53
Salmonella
typhi
78.12 19.53 19.53 – 19.53 4.88
Gram-positive
bacteria
Staphylococcus
aureus
N78.12 N78.12 N78.12 – N78.12 9.76
Bacillus
subtilis
39.06 9.76 4.88 – 9.76 9.76
Fungi
Candida
albicans
78.12 19.53 19.53 – 19.53 4.88
Candida
gabrata
78.12 19.53 19.53 – 19.53 4.88
Microsporum
audorium
39.06 9.76 9.76 9.76 2.44
(–): Not tested because samples were not active by disc diffusion.
a
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for 24 h. The assay was repeated twice. Microbial growth was
determined by observing the change of colour in the wells (red
when there is no growth and yellow when there is growth). The
lowest concentration showing no colour change was considered
as the MIC.
For the determination of MMC, a portion of liquid (5 µl)
from each well that showed no change in colour was plated on
MHA and incubated at 37 °C for 24 h. The lowest concentration
that yielded no growth after this sub-culturing was taken as the
MMC.
3. Results and discussions
The structures of the isolated compounds were established
using spectroscopic analysis, especially, NMR spectra in
conjunction with 2D experiments, COSY, HMQC and
HMBC, and direct comparison with published information
from literature data. The compounds isolated from the stem bark
of T. afzelii (Fig. 1) were found to be three alkaloids and one
terpenoid. The alkaloids were identified as Kokusaginine (1),
Maculine (2) and Nkolbisine (4) while the isolated terpenoid
was a known Lupeol (3). The isolation of Maculine and
Kokusaginine from Esenbeckia almawillia and E. grandifolia,
two plants of the family Rutaceae was previously reported
(Oliveira et al., 1996) whilst Nkolbisine was also isolated from
T. nobilis (Al-Rehaily et al., 2003), another plant of the genus
Teclea.Table 2
Minimal inhibition concentration (μg/ml) of the crude extracts, compounds
isolated from T. afzelii and reference antibiotics
Microorganisms Tested samples a
Crude extract Isolated compounds
TAE 1 2 3 4 RA
Mycobacteria
M. smegmatis 156.25 N312.50 156.25 312.50 N312.50 0.61
Gram-negative
bacteria
Escherichia coli 19.53 4.88 N78.12 78.12 – 4.88
Pseudomonas
aeruginosa
N78.12 N78.12 39.06 – N78.12 9.76
Salmonella
typhi
39.06 9.76 9.76 – 9.76 2.44
Gram-positive
bacteria
Staphylococcus
aureus
N78.12 39.06 N78.12 – N78.12 4.88
Bacillus subtilis 19.53 4.88 2.44 – 4.88 4.88
Fungi
Candida
albicans
39.06 9.76 9.76 – 9.76 2.44
Candida
gabrata
39.06 9.76 9.76 – 9.76 2.44
Microsporum
audorium
19.53 4.88 4.88 4.88 1.22
(–): Not tested because samples were not active by disc diffusion.
a The Tested samples were crude extract from T. afzelii (TAE), 1: Kokusaginine;
2: Maculine; 3: Lupeol; 4: Kolbisine; RA: Reference antibiotics (Gentamycin for
bacteria, Nystatin for yeasts; Ciprofloxacin forM. smegmatis).
The Tested samples were crude extract from T. afzelii (TAE), 1: Kokusaginine;
2: Maculine; 3: Lupeol; 4: Kolbisine; RA: Reference antibiotics (Gentamycin for
bacteria, Nystatin for yeasts; Ciprofloxacin for M. smegmatis).The presence of alkaloids in many Teclea species is well
known (Al-Rehaily et al., 2003; Tarus et al., 2005; Waffo et al.,
2007). Therefore, the isolation of the three alkaloids from
T. afzelii is in accordance with documented reports. The
antimicrobial activities of the isolated compounds as well as that
of the crude extract are reported in Tables 1–3.
The results of the diffusion test (Table 1) showed that only
compound 1was active on all the tested microbial species, while
other compounds as well as the crude extract showed selective
activity. The inhibition effect of the crude extract from T. afzelii
and that of compounds 2 and 4 was observed on seven of the
eight (87.5%) tested organisms. Compound 3 appeared to be the
less active compound, its inhibition potency been observed only
on E. coli. The difference observed in the activity of the tested
compounds on E. coli and S. typhi, two bacteria of the family
Enterobacteriaceae appeared to be strange. However, this might
be related to the intrinsic specificity of the tested microbial
species, or to the mode of action of the tested compounds.
The results of the MIC determination (Table 2) showed
that the MIC values were ranged from 19.53 to 39.06 µg/ml
were observed with the crude extract on 6 of the 9 tested
microorganisms. This extract was moderately active on
M. smegmatis, with greater MIC value (156.25 µg/ml).
This experiment also confirmed to good activity of com-
pounds 1, 2 and 4 on fungi, Gram-positive and negative
bacteria, as observed with the diffusion assay. However, A part
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compounds varied from 2.44 to 39.06 µg/ml onmost of the tested
microorganisms. The lowest MIC value (2.44 µg/ml) was
observed with compound 2 on B. subtilis. This value was 2 fold
lower than that of gentamycin used as reference antibiotic. The
MIC values equal to that of the RA (4.88 µg/ml) were observed
with compounds 1 and 4 on B. subtilis and compound 2 on
E. coli. These data highlighted the selective activity activities of
compounds 1, 2 and 4 as well as that of the crude extract on the
tested microorganisms. This shows that the inhibition potency of
these samples could be considered as very promising in the
perspective of the development of antimicrobial drugs, with both
antibacterial and antifungal activities. This can also be confirmed
by the results of the MMC determination reported on Table 3. All
the MMC values obtained were not more than four fold greater
than the corresponding MICs, showing that cidal effect of the
tested samples could be expected on most of the tested organisms
(Carbonnelle et al., 1987; Mims et al., 1993). The MMC results
also confirmed the inefficacy of the extract and compounds from
T. afzelii on M. smegmatis. This indicates that an interesting
inhibition effect onM. tuberculosis could not be expected as the
sensitivity of this microbial species was found to be closer to
M. smegmatis, a non pathogenic agent (Newton et al., 2002).
To the best of our knowledge, the antimicrobial activity of
this plant as well as that of the tested alkaloids is being reported
for the first time. Nevertheless, many alkaloids are known to
possess antibacterial and antifungal activities (Bruneton, 1999;
Cowan, 1999). Newton et al. (2002) have also documented the
antimicrobial activity of two natural alkaloids, sanguinarine and
chelerythrine, isolated from the roots of Sanguinaria cadensis.
The present study provide an important baseline information
for the use of the crude extract from T. afzelii as well as that of
the isolated alkaloids in the treatment of infections associated to
the sensitive pathogens studied. Their pharmacological and
cytotoxicity studies are being considered as our future objective,
to confirm these samples as potential therapeutic agents.
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